Serum prothrombin conversion accelerator en es it fr

Serum prothrombin conversion accelerator Brand names, Serum prothrombin conversion accelerator Analogs

Serum prothrombin conversion accelerator Brand Names Mixture

  • No information avaliable

Serum prothrombin conversion accelerator Chemical_Formula

C1972H3076N560O597S28

Serum prothrombin conversion accelerator RX_link

http://www.rxlist.com/cgi/generic3/novoseven.htm

Serum prothrombin conversion accelerator fda sheet

Serum prothrombin conversion accelerator msds (material safety sheet)

Serum prothrombin conversion accelerator Synthesis Reference

No information avaliable

Serum prothrombin conversion accelerator Molecular Weight

45079.1

Serum prothrombin conversion accelerator Melting Point

58 oC (Petersen, L.C. et al., Eur. J. Biochem 261: 124-129 (1999)).

Serum prothrombin conversion accelerator H2O Solubility

No information avaliable

Serum prothrombin conversion accelerator State

Liquid

Serum prothrombin conversion accelerator LogP

-0.311

Serum prothrombin conversion accelerator Dosage Forms

Solution (IV injection); Solution (IV infusion); Tablet; Powder for solution

Serum prothrombin conversion accelerator Indication

For treatment of hemorrhagic complications in hemophilia A and B

Serum prothrombin conversion accelerator Pharmacology

Used in the treatment of bleeding episodes in hemophilia A or B. NovoSeven is recombinant Factor VIIa and, when complexed with tissue factor can activate coagulation Factor X to Factor Xa, as well as coagulation Factor IX to Factor IXa. Factor Xa, in complex with other factors, then converts prothrombin to thrombin, which leads to the formation of a hemostatic plug by converting fibrinogen to fibrin and thereby inducing local clotting.

Serum prothrombin conversion accelerator Absorption

No information avaliable

Serum prothrombin conversion accelerator side effects and Toxicity

No information avaliable

Serum prothrombin conversion accelerator Patient Information

No information avaliable

Serum prothrombin conversion accelerator Organisms Affected

Humans and other mammals